Nur Exone Biologic announced it raised $1.02 Million in an initial filing from an offering of $1.02 Million
PRIVATEMar 25, 2024
Amount Raised
$1.02 Million
Round Type
Seed
HaifaBiotechnology
Company Information
Company
NurExone Biologic
Location
MINUS 1 ENTRY, GROUND FLOOR OF BLDG B
Haifa, Haifa District, Israel
About
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.
Fundz sees it the moment NurExone Biologic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.